AttributesValues
type
value
  • Summary Acute bronchitis in healthy patient in mainly related to virus. Intra-cellular bacteria, Mycoplasma pneumonia are rarely involved. For these reasons, macrolides or cyclines (except for children) are justified in first line treatment. For patients with acute exacerbation of chronic bronchitis, the choice of the treatment needs to be discuss. At the initial stage, most of the pathogens involved are those of acute bronchitis. Antibiotic is only prescribes for the prevention of a superinfection; this kind of prophylaxis has to be evaluated. Few days after, histological due to modifications of bronchi, a superinfection can occur which needs a curative treatment. In most of the data reported the literature, there is no distinction between the two periods of the disease. It is interesting to point out that associated treatments such as kinesitherapy, corticosteroids can modify the natural course of bronchitis. There are not evaluated as associated treatment in the different clinical trials.
Subject
  • Mycoplasma
  • Pathogenic bacteria
  • Bacteria described in 1963
  • United States administrative law
  • Villages in Azamgarh district
  • Azamgarh
part of
is abstract of
is hasSource of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software